Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector?

North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products. Valued at $232.4 billion by market cap, ABT is a global leader in the large and growing in-vitro diagnostic market and its products include pharmaceuticals, nutritional, diagnostics, and vascular products.

Companies worth $200 billion or more are generally described as “mega-cap stocks,” and ABT definitely fits that description, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical devices industry. ABT offers a diverse range of healthcare products helping to mitigate risks and capture opportunities in various markets. With a global presence in over 160 countries, ABT can tap into different economic conditions. The company's strong focus on research and development (R&D) enables it to develop innovative products and technologies, giving it a competitive advantage.